This announcement is a separate document:
康方生物:自願公告 - 國家藥品監督管理局批准伊喜寧 (伊努西單抗,PCSK9) 的新藥上市申請
AKESO: VOLUNTARY ANNOUNCEMENT - NMPA APPROVED THE NEW DRUG APPLICATION OF (EBRONUCIMAB, PCSK9)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.